Central Asia vs Norway: Proportion of the target population who received the final dose of
Central Asia
59.0%
in 2024
Norway
91.0%
in 2024
Central Asia rank
8th
Norway rank
9th
Proportion of the target population who received the final dose of over time
- Central Asia
- Norway
How they compare
Norway currently reports 91.0% against 59.0% in Central Asia, a difference of 32.0%.
That makes Norway's figure about 1.5 times Central Asia's.
Across all 8 years both countries report, Norway has been ahead every year.
Central Asia ranks 8th and Norway ranks 9th of 35 groups.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central Asia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.0% | 87.3% | 79.3% | Norway |
| 2020s | 52.0% | 90.6% | 38.6% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central Asia or Norway?
- Norway, at 91.0% against 59.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central Asia and Norway?
- 32.0%, with Norway ahead.
- How many years of comparable data are there for Central Asia and Norway?
- 8 years are reported by both, from 2017 to 2024.
- How do Central Asia and Norway rank globally for proportion of the target population who received the final dose of?
- Central Asia ranks 8th and Norway ranks 9th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.